Cabaletta Bio Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.51

+0.18 (+7.73%)

As of Feb 8, 2:02 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 13 81%

Hold 3 19%

Sell 0 0%

Price Target

Analyst Price Target +1,485.3% upside

Low Target $29.42

Average Target $39.79

High Target $58.63

Current Price $2.51

Current
$2.51

Target
$39.79

$29.42 $39.79 avg $58.63

Scenario Analysis

Bear Case

$29.42

1,072.1%

Low target

Base Case

$39.79

+1,485.3%

Avg target

Bull Case

$58.63

+2,235.9%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$43.98

-94.3% from high

52-Week Low

$34.26

+-92.7% from low

Target vs 52W High

$39.79

-9.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%